HKPD
Cellyan Biotechnology Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · HK
$0.13
−8.86%Margins
Gross margin
11.3%
EBITDA margin
-1.9%
EBIT margin
-2.6%
Net margin
-3.4%
FCF margin
-0.9%
-12.1%
Return on equity
-9.1%
Return on assets
-8.0%
Return on invested capital
3.00x
Asset turnover
-$182.4K
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026